InvestorsHub Logo
Followers 99
Posts 3689
Boards Moderated 0
Alias Born 01/13/2018

Re: keepsmiling post# 2439

Wednesday, 06/05/2019 7:38:28 PM

Wednesday, June 05, 2019 7:38:28 PM

Post# of 7494
In the RBC investor conference material page 19 says they will commence trials for trauma/soft tissue healing. this is the only trials that will help with scarring they will be doing in the US.

Other than that there won't be any, doesn't need to be actually. Acne scarring, use in tattoo removal healing I don't think they need one, I could be wrong. Other than that there won't be any trials for scarring/cosmetic use.

In Japan the JPMDA covers burns and trauma wounds and there shouldn't be any trials for scarring/cosmetic uses.

I may have misunderstood what you guys were talking about, but, as far as I know help with scarring is only the trauma/soft tissue repair? I think, other cosmetic uses there won't be trials right?

Anything else is like 2020 and beyond, that is why I see buyout in 2020 and hope for it. Not just for the company, but, the patients and technology, a large company can have everything commencing ASAP and over in 1/5 the time.

That's just the realities of the almighty $$ and Avita won't have that kind of $$ for a couple years out. Where for a larger company that is pocket change, literally.

Peace out.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RCEL News